Ann: PAT-DX1 Active in Pre-clinical Cancer Models, page-144

First 144 Last

Share
Profile

Follow
dmax

522 Posts.

6

17/09/17

23:04

Post #: 27277191
Share

Originally posted by Iceberg ↑

I did not think Akki was speculating about an impending buy-out deal for PAB. She was merely commenting that if an early stage cancer biotech has a very good pre-clinical asset (...and from what we know PAT DX-1 ticks a number of boxes in this regard as per the most recent ASX release - i.e., novel, newly discovered mechanism of action, good IP, can target multiple cancers esp solid tumours, potential to work in synergy/combined therapy with other therapies, has the ability to be conjugated to radio nucleotides or nano particles etc etc), then there are many precedents for early stage/pre-clinical buyouts by big pharma. She was also stating (not speculating) on what we know now about the pre-clinical characteristics of PAT DX-1 in a very measured and informed way.

In regard to FDA approvals - for most small cap/early stage biotechs listed on the ASX, the path to FDA approval will usually come after the takeover by a big pharma parent. In this regard she is not speculating either and just stating the normal course of events for any successful early stage/discovery focussed biotech.

Jim, I am sure you would like to see the PAB price fall to 0.004-0.006 cents again and then sell at 2c!!

Long-term PABsters be aware - the traders are very good at downramping and upramping - just have a look at the historical posts for some of the "traders" the ill-founded, inconsistencies and contradictory comments for any given stock will amaze!!

Expand

Seems you have a good insight and are a long time follower of pab IB ?

PAB Price at posting: 1.9¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

DRO

Droneshield shares move up on $13.5M US govt contract

LMS

Litchfield boosts its copper, base and precious metals footprint in the NT with acquisitions

WAF

West African Res jumps on claim mine safe under Burkina Faso's junta; HotCopper ponders Russia

OCC

Orthocell wins first international approval for nerve repair product

TMK

TMK Energy kicks off drilling for new pilot wells in Mongolia's vastly underexplored Gobi

There are more pages in this discussion • 10 more messages in this thread...

First 144 Last

Add PAB (ASX) to my watchlist

(20min delay)
Last 0.4¢		Change 0.001(16.7%)		Mkt cap ! $7.201M

Open	High	Low	Value	Volume
0.3¢	0.4¢	0.3¢	$1.479K	422.7K

Buyers (Bids)

No.	Vol.	Price($)
32	25195209	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	22489307	15

View Market Depth

No.	Vol.	Price($)
32	25195209	0.003
26	36631332	0.002
12	51351998	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	22489307	15
0.005	11004512	9
0.006	8546450	7
0.007	6426356	4
0.008	1221910	4

Last trade - 10.56am 08/10/2024 (20 minute delay)

PAB (ASX) Chart

Ann: PAT-DX1 Active in Pre-clinical Cancer Models, page-144

Droneshield shares move up on $13.5M US govt contract

Litchfield boosts its copper, base and precious metals footprint in the NT with acquisitions

West African Res jumps on claim mine safe under Burkina Faso's junta; HotCopper ponders Russia

Orthocell wins first international approval for nerve repair product

TMK Energy kicks off drilling for new pilot wells in Mongolia's vastly underexplored Gobi

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: PAT-DX1 Active in Pre-clinical Cancer Models, page-144

Top Stories

Droneshield shares move up on $13.5M US govt contract

Litchfield boosts its copper, base and precious metals footprint in the NT with acquisitions

West African Res jumps on claim mine safe under Burkina Faso's junta; HotCopper ponders Russia

Orthocell wins first international approval for nerve repair product

TMK Energy kicks off drilling for new pilot wells in Mongolia's vastly underexplored Gobi

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News